# Spark Therapeutics, Inc. — Form D

Spark Therapeutics, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2014-06-06. The offering totals $72.8M, of which $72.8M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2014-06-06
- Form: D
- Accession: 0001609351-14-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $72.8M
- Amount sold: $72.8M
- Investors: 28
- Date of first sale: 2014-05-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-218710

## Issuer

- Name: Spark Therapeutics, Inc.
- CIK: 0001609351
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 3501 CIVIC CENTER BOULEVARD, PHILADELPHIA, PA, 19104
- Phone: 888-772-7560

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Steven M Altschuler | Director | New York, NY |
| Arthur M Dantchik | Director | Philadelphia, PA |
| Lars M Ekman, M.D. Ph.D. | Director | Philadelphia, PA |
| Jeffrey D Marrazzo | Director | Philadelphia, PA |
| Anand M Mehra | Director | Philadelphia, PA |
| Elliott M Sigal | Director | Philadelphia, PA |
| Rogerio M Vivaldi | Director | Philadelphia, PA |
| Joseph W La Barge | Executive Officer | Philadelphia, PA |
| Jeffrey D Marrazzo | Executive Officer | Philadelphia, PA |

## More

- [CIK 1609351 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1609351&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001609351-14-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.